CellSource Co Ltd
TSE:4880

Watchlist Manager
CellSource Co Ltd Logo
CellSource Co Ltd
TSE:4880
Watchlist
Price: 1 174 JPY 0.43% Market Closed
Market Cap: 23.3B JPY
Have any thoughts about
CellSource Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one CellSource Co Ltd stock under the Base Case scenario is 975.9 JPY. Compared to the current market price of 1 174 JPY, CellSource Co Ltd is Overvalued by 17%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
975.9 JPY
Overvaluation 17%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
CellSource Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CellSource Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CellSource Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about CellSource Co Ltd

Provide an overview of the primary business activities
of CellSource Co Ltd.

What unique competitive advantages
does CellSource Co Ltd hold over its rivals?

What risks and challenges
does CellSource Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for CellSource Co Ltd.

Provide P/S
for CellSource Co Ltd.

Provide P/E
for CellSource Co Ltd.

Provide P/OCF
for CellSource Co Ltd.

Provide P/FCFE
for CellSource Co Ltd.

Provide P/B
for CellSource Co Ltd.

Provide EV/S
for CellSource Co Ltd.

Provide EV/GP
for CellSource Co Ltd.

Provide EV/EBITDA
for CellSource Co Ltd.

Provide EV/EBIT
for CellSource Co Ltd.

Provide EV/OCF
for CellSource Co Ltd.

Provide EV/FCFF
for CellSource Co Ltd.

Provide EV/IC
for CellSource Co Ltd.

Show me price targets
for CellSource Co Ltd made by professional analysts.

What are the Revenue projections
for CellSource Co Ltd?

How accurate were the past Revenue estimates
for CellSource Co Ltd?

What are the Net Income projections
for CellSource Co Ltd?

How accurate were the past Net Income estimates
for CellSource Co Ltd?

What are the EPS projections
for CellSource Co Ltd?

How accurate were the past EPS estimates
for CellSource Co Ltd?

What are the EBIT projections
for CellSource Co Ltd?

How accurate were the past EBIT estimates
for CellSource Co Ltd?

Compare the revenue forecasts
for CellSource Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of CellSource Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of CellSource Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of CellSource Co Ltd compared to its peers.

Compare the P/E ratios
of CellSource Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing CellSource Co Ltd with its peers.

Analyze the financial leverage
of CellSource Co Ltd compared to its main competitors.

Show all profitability ratios
for CellSource Co Ltd.

Provide ROE
for CellSource Co Ltd.

Provide ROA
for CellSource Co Ltd.

Provide ROIC
for CellSource Co Ltd.

Provide ROCE
for CellSource Co Ltd.

Provide Gross Margin
for CellSource Co Ltd.

Provide Operating Margin
for CellSource Co Ltd.

Provide Net Margin
for CellSource Co Ltd.

Provide FCF Margin
for CellSource Co Ltd.

Show all solvency ratios
for CellSource Co Ltd.

Provide D/E Ratio
for CellSource Co Ltd.

Provide D/A Ratio
for CellSource Co Ltd.

Provide Interest Coverage Ratio
for CellSource Co Ltd.

Provide Altman Z-Score Ratio
for CellSource Co Ltd.

Provide Quick Ratio
for CellSource Co Ltd.

Provide Current Ratio
for CellSource Co Ltd.

Provide Cash Ratio
for CellSource Co Ltd.

What is the historical Revenue growth
over the last 5 years for CellSource Co Ltd?

What is the historical Net Income growth
over the last 5 years for CellSource Co Ltd?

What is the current Free Cash Flow
of CellSource Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for CellSource Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
CellSource Co Ltd

Current Assets 5.2B
Cash & Short-Term Investments 4.4B
Receivables 430.9m
Other Current Assets 376.4m
Non-Current Assets 1.7B
PP&E 1B
Intangibles 54.3m
Other Non-Current Assets 594.7m
Current Liabilities 482.3m
Accounts Payable 84.8m
Accrued Liabilities 35.6m
Other Current Liabilities 361.9m
Non-Current Liabilities 212m
Other Non-Current Liabilities 212m
Efficiency

Earnings Waterfall
CellSource Co Ltd

Revenue
4.4B JPY
Cost of Revenue
-1.6B JPY
Gross Profit
2.9B JPY
Operating Expenses
-2.3B JPY
Operating Income
566.4m JPY
Other Expenses
55.8m JPY
Net Income
622.2m JPY

Free Cash Flow Analysis
CellSource Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

CellSource Co Ltd's profitability score is 68/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROE
68/100
Profitability
Score

CellSource Co Ltd's profitability score is 68/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

CellSource Co Ltd's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
93/100
Solvency
Score

CellSource Co Ltd's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
CellSource Co Ltd

Wall Street analysts forecast CellSource Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CellSource Co Ltd is 1 632 JPY with a low forecast of 1 616 JPY and a high forecast of 1 680 JPY.

Lowest
Price Target
1 616 JPY
38% Upside
Average
Price Target
1 632 JPY
39% Upside
Highest
Price Target
1 680 JPY
43% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CellSource Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CellSource Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

CellSource Co Ltd Logo
CellSource Co Ltd

Country

Japan

Industry

Life Sciences Tools & Services

Market Cap

23.3B JPY

Dividend Yield

0.43%

Description

CellSource Co., Ltd. engages in regenerative medicine related business. The company is headquartered in Shibuya-Ku, Tokyo-To and currently employs 90 full-time employees. The company went IPO on 2019-10-28. The firm operates in two business segments. The Regenerative Medicine Related business segment is engaged in the provision of contracted services for processing tissues and cells derived from fat and blood to medical institutions, and support services for regenerative medicine laws and regulations related to safety assurance such as regenerative medicine, as well as sales of medical equipment. The Consumer business segment is engaged in the sales of cosmetics and facial products to general consumers.

Contact

TOKYO-TO
Shibuya-Ku
2F, Shibuya Mitake Bldg., 1-19-5, Shibuya
+81364555308.0
www.cellsource.co.jp

IPO

2019-10-28

Employees

90

Officers

Executive Chairman & MD
Mr. Masayuki Yamakawa M.D.
President, CEO & Representative Director
Mr. Takashi Sawada
Executive Officer, GM of Mgt. HQ., Head of Mgt. HQ. & GM of Administration
Mr. Katsuji Onishi
CXO, Chief Transformation Officer & Representative Director
Mr. Masato Tsumamoto
Executive Officer & Head of Medical Affairs Headquarters
Mr. Hirohiko Hanaki
Executive Officer & Head of Corporate Planning Headquarters
Kaoru Hosoda
Show More
Executive Officer, Head of CPC Headquarters & Director
Mr. Futa Asada
Show Less

See Also

Discover More
What is the Intrinsic Value of one CellSource Co Ltd stock?

The intrinsic value of one CellSource Co Ltd stock under the Base Case scenario is 975.9 JPY.

Is CellSource Co Ltd stock undervalued or overvalued?

Compared to the current market price of 1 174 JPY, CellSource Co Ltd is Overvalued by 17%.

Back to Top